Skip to main content
TRUPANION, INC. logo

TRUPANION, INC. — Investor Relations & Filings

Ticker · TRUP ISIN · US8982021060 LEI · 549300J86GFKIDGMQP18 US Financial and insurance activities
Filings indexed 1,499 across all filing types
Latest filing 2022-11-23 Director's Dealing
Country US United States of America
Listing US TRUP

About TRUPANION, INC.

https://trupanion.com/

Trupanion, Inc. provides medical insurance for cats and dogs through a subscription-based model. The company's core offering is a policy designed to cover significant, unexpected veterinary costs arising from new illnesses and injuries. Coverage extends to hereditary and congenital conditions, diagnostic tests, surgeries, medications, and hospital stays, but excludes routine or preventative care. A key feature of its service is the ability to pay veterinarians directly at the time of checkout, reducing the policyholder's immediate out-of-pocket expense. Trupanion's plans typically cover 90% of eligible costs with no payout limits, providing lifelong coverage for enrolled pets. Policyholders have the flexibility to use any licensed veterinarian, specialist, or emergency hospital.

Recent filings

Filing Released Lang Actions
FORM 4
Director's Dealing
2022-11-23 English
FORM 4
Director's Dealing
2022-11-11 English
FORM 4
Director's Dealing
2022-11-07 English
10-Q
Interim / Quarterly Report Q3 2022
2022-11-04 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, which is used for reporting unscheduled material events or corporate changes. The text includes multiple items: Item 2.02 (Results of Operations and Financial Condition) referencing a press release of quarterly financial results, Item 5.02 (Departure of Directors or Certain Officers) announcing a director's resignation, and Item 7.01 (Regulation FD Disclosure) about an acquisition agreement. The document itself does not contain detailed financial statements or comprehensive financial analysis but rather announces events and includes press releases as exhibits. The presence of a director resignation points to management changes, and the acquisition announcement relates to M&A activity. However, since the document is a Form 8-K reporting multiple events, including management changes and acquisition announcement, the best classification is Regulatory Filings (RNS), which is the fallback category for miscellaneous filings that do not fit neatly into other categories. The document is not a full Annual Report, Interim Report, Earnings Release, or standalone M&A filing. Therefore, the classification is RNS with high confidence.
2022-11-03 English
FORM 4
Director's Dealing
2022-10-28 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.